The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study
Open accessAbstract
BACKGROUND: Most neonatal and infantile-onset epilepsies have presumed genetic aetiologies, and early genetic diagnoses have the potential to inform clinical management and improve outcomes. We therefore aimed to determine the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in this population. METHODS: We conducted an international, multicentre, cohort study (Gene-STEPS), which is a pilot study of the International Precision Child Health Partnership (IPCHiP). IPCHiP is a consortium of four paediatric centres with tertiary-level subspecialty services in Australia, Canada, the UK, and the USA. We recruited infants with new-onset epilepsy or complex febrile seizures from IPCHiP centres, who were younger than 12 months at seizure onset. We excluded infants with simple febrile seizures, acute provoked seizures, known acquired cause, or known genetic cause. Blood samples were collected from probands and available biological parents. Clinical data were collected from medical records, treating clinicians, and parents. Trio genome sequencing was done when both parents were available, and duo or singleton genome sequencing was done when one or neither parent was available. Site-specific protocols were used for DNA extraction and library preparation. Rapid genome sequencing and analysis was done at clinically accredited laboratories, and results were returned to families. We analysed summary statistics for cohort demographic and clinical characteristics and the timing, diagnostic yield, and clinical impact of rapid genome sequencing. FINDINGS: Between Sept 1, 2021, and Aug 31, 2022, we enrolled 100 infants with new-onset epilepsy, of whom 41 (41%) were girls and 59 (59%) were boys. Median age of seizure onset was 128 days (IQR 46-192). For 43 (43% [binomial distribution 95% CI 33-53]) of 100 infants, we identified genetic diagnoses, with a median time from seizure onset to rapid genome sequencing result of 37 days (IQR 25-59). Genetic diagnosis was associated with neonatal seizure onset versus infantile seizure onset (14 [74%] of 19 vs 29 [36%] of 81; p=0·0027), referral setting (12 [71%] of 17 for intensive care, 19 [44%] of 43 non-intensive care inpatient, and 12 [28%] of 40 outpatient; p=0·0178), and epilepsy syndrome (13 [87%] of 15 for self-limited epilepsies, 18 [35%] of 51 for developmental and epileptic encephalopathies, 12 [35%] of 34 for other syndromes; p=0·001). Rapid genome sequencing revealed genetic heterogeneity, with 34 unique genes or genomic regions implicated. Genetic diagnoses had immediate clinical utility, informing treatment (24 [56%] of 43), additional evaluation (28 [65%]), prognosis (37 [86%]), and recurrence risk counselling (all cases). INTERPRETATION: Our findings support the feasibility of implementation of rapid genome sequencing in the clinical care of infants with new-onset epilepsy. Longitudinal follow-up is needed to further assess the role of rapid genetic diagnosis in improving clinical, quality-of-life, and economic outcomes. FUNDING: American Academy of Pediatrics, Boston Children's Hospital Children's Rare Disease Cohorts Initiative, Canadian Institutes of Health Research, Epilepsy Canada, Feiga Bresver Academic Foundation, Great Ormond Street Hospital Charity, Medical Research Council, Murdoch Children's Research Institute, National Institute of Child Health and Human Development, National Institute for Health and Care Research Great Ormond Street Hospital Biomedical Research Centre, One8 Foundation, Ontario Brain Institute, Robinson Family Initiative for Transformational Research, The Royal Children's Hospital Foundation, University of Toronto McLaughlin Centre.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, a recent study of rapid genome sequencing (median time from seizure onset to sequencing result of 37 days) in infants with seizures beginning under one year of age, identified the genetic aetiology in 46% of 100 children, with clinical utility in 56%, prognostic counselling in 86% and genetic counselling implications in all those with a pathogenic variant 157 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [157]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A 2023 genome analysis of infants with seizures beginning in the first year of life identified a genetic cause in 43% of 100 infants, and all had implications for disease management 157 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [157]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, a 2023 genome sequencing study of infants presenting with seizures under age 1 year identified the causal variant in 43% with immediate treatment implications in 56%, informing additional evaluation in 65% and prognostic counselling in 86% 157 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [157]
The cited source says what the claim attributes to it.
In the citing paper
“This international collaborative study analysed the yield of rapid genome sequencing in infants presenting with seizures in the first year of life and highlighted the utility in determining management, prognostic and reproductive counselling.”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
Zuberi, S. M., Wirrell, E., Yozawitz, E., Wilmshurst, J. M., Specchio, N., Riney, K., Pressler, R., Auvin, S., Samia, P., Hirsch, E., et al. (2022) · Epilepsia · doi:10.1111/epi.17239 · Cited by 934
Self-citation100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report
The 100, 0. G. P. P. I. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035790 · Cited by 716
Manickam, K., McClain, M. R., Demmer, L. A., Biswas, S., Kearney, H. M., Malinowski, J., Massingham, L. J., Miller, D., Yu, T. W., & Hisama, F. M. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01242-6 · Cited by 639
The genetic landscape of the epileptic encephalopathies of infancy and childhood
McTague, A., Howell, K. B., Cross, J. H., Kurian, M. A., & Scheffer, I. E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00250-1 · Cited by 604
Self-citationSymonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., et al. (2019) · Brain · doi:10.1093/brain/awz195 · Cited by 459
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
Hamdan, F. F., Myers, C. T., Cossette, P., Lemay, P., Spiegelman, D., Laporte, A. D., Nassif, C., Diallo, O., Monlong, J., Cadieux-Dion, M., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.008 · Cited by 445
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
Feng, Y.-C. A., Howrigan, D. P., Abbott, L. E., Tashman, K., Cerrato, F., Singh, T., Heyne, H., Byrnes, A., Churchhouse, C., Watts, N., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.020 · Cited by 297
Self-citationDe novo variants in neurodevelopmental disorders with epilepsy
EuroEPINOMICS RES Consortium, Heyne, H. O., Singh, T., Stamberger, H., Abou Jamra, R., Caglayan, H., Craiu, D., De Jonghe, P., Guerrini, R., Helbig, K. L., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0143-7 · Cited by 289
Self-citation
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationGenetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine
Snyder, H., Jain, P., RamachandranNair, R., Jones, K., & Whitney, R. (2024) · Genes · doi:10.3390/genes15030266 · Cited by 42
Self-citationSpecchio, N., Trivisano, M., Aronica, E., Balestrini, S., Arzimanoglou, A. A., Colasante, G., Cross, J. H., Jóźwiak, S., Wilmshurst, J. M., Vigevano, F., et al. (2024) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(24)00196-2 · Cited by 39
Self-citationLaFlamme, C. W., Rastin, C., Sengupta, S., Pennington, H. E., Russ-Hall, S. J., Schneider, A. L., Bonkowski, E. S., Almanza Fuerte, E. P., Allan, T. J., Zalusky, M. P.-G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50159-6 · Cited by 31
Self-citationCavirani, B., Spagnoli, C., Caraffi, S. G., Cavalli, A., Cesaroni, C. A., Cutillo, G., GIORGIS, V. D., Frattini, D., Marchetti, G. B., Masnada, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021248 · Cited by 27
Metadata
- Authors
- D'Gama, A. M., Mulhern, S., Sheidley, B. R., Boodhoo, F., Buts, S., Chandler, N. J., Cobb, J., Curtis, M., Higginbotham, E. J., Holland, J., Khan, T., Koh, J., Liang, N. S. Y., McRae, L., Nesbitt, S. E., Oby, B. T., Paternoster, B., Patton, A., Rose, G., Scotchman, E., Valentine, R., Wiltrout, K. N., Hayeems, R. Z., Jain, P., Lunke, S., Marshall, C. R., Rockowitz, S., Sebire, N. J., Stark, Z., White, S. M., Chitty, L. S., Cross, J. H., Scheffer, I. E., Chau, V., Costain, G., Poduri, A., Howell, K. B., & McTague, A.
- Affiliations
- Victorian Clinical Genetics Services (AU)
- Boston Children's Hospital (US)
- Great Ormond Street Hospital (GB)
- Universitätsklinikum Aachen (DE)
- Murdoch Children's Research Institute (AU)
- Hospital for Sick Children (CA)
- SickKids Foundation (CA)
- University of Toronto (CA)
- Frimley Park Hospital (GB)
- The University of Melbourne (AU)
- Royal Children's Hospital (AU)
- Corresponding author
- McTague, Amy
- ORCID
- Sheidley, Beth R
- Buts, Sarah
- Chandler, Natalie J
- Cobb, Joanna
- Curtis, Meredith
- Higginbotham, Edward J
- Holland, Jonathon
- Khan, Tayyaba
- Liang, Nicole S Y
- McRae, Lyndsey
- Oby, Brandon T
- Paternoster, Ben
- Rose, Graham
- Scotchman, Elizabeth
- Valentine, Rozalia
- Wiltrout, Kimberly N
- Hayeems, Robin Z
- Jain, Puneet
- Lunke, Sebastian
- Marshall, Christian R
- Rockowitz, Shira
- Sebire, Neil J
- Stark, Zornitza
- White, Susan M
- Chitty, Lyn S
- Cross, J Helen
- Scheffer, Ingrid E
- Chau, Vann
- Costain, Gregory
- Poduri, Annapurna
- Howell, Katherine B
- McTague, Amy
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 22
- Issue
- 9
- Pages
- 812-825
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC11860300
- OpenAlex
- W4385889024
- Cited by
- 80
- References
- 33
- Citations by year
- 2026: 19 · 2025: 30 · 2024: 28 · 2023: 3
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Update notices
- erratum (2023-12-01)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Neurology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research
- Medical Research Council (MR/T007087/1)
- National Health and Medical Research Council (2006841)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD105351, T32HD098061)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- infantile epilepsy, rapid genome sequencing, neonatal seizures, complex febrile seizures, genetic diagnosis, diagnostic yield, clinical utility
- MeSH terms
- Child, Seizures, Febrile, Epilepsy, Feasibility Studies, Female, Humans, Infant, Newborn, Male, Ontario, Pilot Projects, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study. https://app.cochat.ai/papers/10.1016/s1474-4422(23)00246-6
- The paper
- D'Gama, A. M., Mulhern, S., Sheidley, B. R., Boodhoo, F., Buts, S., Chandler, N. J., Cobb, J., Curtis, M., Higginbotham, E. J., Holland, J., Khan, T., Koh, J., Liang, N. S. Y., McRae, L., Nesbitt, S. E., Oby, B. T., Paternoster, B., Patton, A., Rose, G., . . . McTague, A. (2023). Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(23)00246-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.